Literature DB >> 1931776

Blindness in patients after external beam irradiation for pituitary adenomas: two cases occurring after small daily fractional doses.

J L Millar1, N A Spry, D S Lamb, J Delahunt.   

Abstract

We report two cases of blindness occurring within 10 months of completion of radiation with 45 Gy in 1.80 Gy fractions given five times weekly. The literature on blindness as a complication of pituitary irradiation is reviewed. There have been no reported cases of total visual loss occurring as a consequence of treatment with fractional doses of less than 2 Gy. Visual loss due to radiation damage usually occurs within two years of completion of treatment in contrast to visual loss due to recurrence or empty sella syndrome, which usually occur more than two years after the completion of therapy. Other causes of blindness not related to the radiation, and potentially reversible, must be considered. However, these causes usually have a distinctively different clinical picture. Fraction size, total dose, and treatment time are all important factors when considering the biological effects of radiation to the pituitary region.

Entities:  

Mesh:

Year:  1991        PMID: 1931776     DOI: 10.1016/s0936-6555(05)80885-4

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  3 in total

1.  Neurocognitive long-term impact of two-field conventional radiotherapy in adult patients with operated pituitary adenomas.

Authors:  Beatriz Lecumberri; Javier Estrada; José García-Uría; Isabel Millán; Luis Felipe Pallardo; Luis Caballero; Tomás Lucas
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

Review 2.  Reevaluation of conventional pituitary irradiation in the therapy of acromegaly.

Authors:  C A Jaffe
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

3.  A Case of Giant Pituitary Adenoma Associated with a Postoperative Mental Disorder That Ultimately Resulted in Bilateral Blindness.

Authors:  Masahiro Tonari; Yuko Nishikawa; Junko Matsuo; Masashi Mimura; Hidehiro Oku; Jun Sugasawa; Naokado Ikeda; Yoshitaka Kurisu; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2020-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.